Cargando…
1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454393/ http://dx.doi.org/10.1016/j.annonc.2021.08.1591 |
_version_ | 1784570483616776192 |
---|---|
author | de Sousa, M.J.P. Caramujo, C. Julio, N. Magalhães, J. Correia Basto, R. Fraga, T. Gomes, I. Ferreira Pazos, I. Sousa, G. |
author_facet | de Sousa, M.J.P. Caramujo, C. Julio, N. Magalhães, J. Correia Basto, R. Fraga, T. Gomes, I. Ferreira Pazos, I. Sousa, G. |
author_sort | de Sousa, M.J.P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8454393 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84543932021-09-21 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study de Sousa, M.J.P. Caramujo, C. Julio, N. Magalhães, J. Correia Basto, R. Fraga, T. Gomes, I. Ferreira Pazos, I. Sousa, G. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454393/ http://dx.doi.org/10.1016/j.annonc.2021.08.1591 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article de Sousa, M.J.P. Caramujo, C. Julio, N. Magalhães, J. Correia Basto, R. Fraga, T. Gomes, I. Ferreira Pazos, I. Sousa, G. 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study |
title | 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study |
title_full | 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study |
title_fullStr | 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study |
title_full_unstemmed | 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study |
title_short | 1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study |
title_sort | 1598p acceptance of sars-cov-2 vaccination among patients with cancer undergoing immunosuppressive therapy: portuguese study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454393/ http://dx.doi.org/10.1016/j.annonc.2021.08.1591 |
work_keys_str_mv | AT desousamjp 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy AT caramujoc 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy AT julion 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy AT magalhaesjcorreia 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy AT bastor 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy AT fragat 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy AT gomesiferreira 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy AT pazosi 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy AT sousag 1598pacceptanceofsarscov2vaccinationamongpatientswithcancerundergoingimmunosuppressivetherapyportuguesestudy |